Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
PULM similar filings
- 12 May 23 Pulmatrix Announces First Quarter 2023 Financial Results and Provides Corporate Update
- 30 Mar 23 Pulmatrix Announces Year-End and Q4 Financial 2022 Results and Provides Corporate Update
- 6 Feb 23 Regulation FD Disclosure
- 3 Feb 23 Regulation FD Disclosure
- 25 Jan 23 Regulation FD Disclosure
- 11 Jan 23 Regulation FD Disclosure
- 4 Jan 23 Pulmatrix Announces Positive Top Line Results from a Phase 1 Study with PUR3100, a Novel Orally Inhaled Dihydroergotamine (DHE), for Acute Migraine
Filing view
External links